Inventaire - your friends and communities are your best library

Mastocytosis: state of the art.

published in: Pathobiology

date of publication: 2007-01-01

Cites articles 47

Date

Title

Authors

2006-08-01

"Occult" mastocytosis with activating c-kit point mutation evolving into systemic mastocytosis associated with plasma cell myeloma and secondary amyloidosis

Peter Valent
2005-01-13

AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec

Yue-Ying Wang, Guangbiao Zhou
2005-10-27

KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival

Claudia Schoch, Torsten Haferlach, Susanne Schnittger
2005-06-21

Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation

Ching-Cheng Chen, Tracy I George, Michael C. Heinrich, Stephen J. Galli, Len Neckers
2004-10-01

CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens.
2004-01-01

KIT mutations are common in testicular seminomas
2004-03-01

Acute myeloid leukaemia with t(8;21) associated with "occult" mastocytosis. Report of an unusual case and review of the literature

Peter Valent
2004-06-01

Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge
2004-01-01

Clinical, genetic, and therapeutic insights into systemic mast cell disease

Ayalew Tefferi
2004-03-01

Response to therapy with interferon alpha-2b and prednisolone in aggressive systemic mastocytosis: report of five cases and review of the literature

Peter Valent
2004-03-01

Treatment of systemic mast cell disease: beyond interferon

Ayalew Tefferi
2003-10-01

Mast cell proliferative disorders: current view on variants recognized by the World Health Organization

Cem Akin, Dean D. Metcalfe
2003-08-01

Increase of bone marrow lymphocytes in systemic mastocytosis: reactive lymphocytosis or malignant lymphoma? Immunohistochemical and molecular findings on routinely processed bone marrow biopsy specimens

Peter Valent
2003-03

One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes
2003-08-01

Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit

Cem Akin, Dean D. Metcalfe
2003-12-24

A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib

Cem Akin, Dean D. Metcalfe, Len Neckers
2003-07-01

Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria

Cem Akin, Dean D. Metcalfe
2003-09-01

Diagnosis and treatment of systemic mastocytosis: state of the art.

Dean D. Metcalfe
2003-07-03

CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy

Rhett P. Ketterling, Nicholas Cross, Jan Cools
2002-06-01

Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease

Peter Valent
2002-03-01

Stem cell factor-induced bone marrow mast cell hyperplasia mimicking systemic mastocytosis (SM): histopathologic and morphologic evaluation with special reference to recently established SM-criteria
2002-02-01

Kit and c-kit mutations in mastocytosis: a short overview with special reference to novel molecular and diagnostic concepts

Antoine Ribadeau Dumas, Peter Valent
2002-12-01

Tryptase a novel biochemical marker of acute myeloid leukemia
2002-02-01

Cutaneous mastocytosis -- clinical heterogeneity

Karin Hartmann
2002-01-01

Myelomastocytic leukemia: myeloid neoplasm characterized by partial differentiation of mast cell-lineage cells
2002-11-29

Mastocytosis: current concepts in diagnosis and treatment

Dean D. Metcalfe
2002-12-01

Treatment of adult systemic mastocytosis with interferon-alpha: results of a multicentre phase II trial on 20 patients

Olivier Lortholary, Loïc Guillevin
2001-07-01

Diagnostic criteria and classification of mastocytosis: a consensus proposal

Dean D. Metcalfe
2001-07-01

Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings

Peter Valent
2001-07-01

Diagnosis of mastocytosis: value of cytochemistry and immunohistochemistry
2001-05-01

Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L).
2001-07-01

Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy

Article - wd:Q34641105

Welcome to Inventaire

the library of your friends and communities

learn more